Faeth Therapeutics (FTH) Assets Average (2021 - 2026)

Faeth Therapeutics (FTH) has 6 years of Assets Average data on file, last reported at $84.1 million in Q1 2026.

• Quarterly Assets Average changed N/A year-over-year to $84.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.1 million (changed N/A YoY) and the FY2025 annual result came in at $34.1 million, down 42.99% from the prior year.
• Assets Average improved to $84.1 million in Q1 2026, from $25.2 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $151.6 million in Q1 2022 to a low of $25.2 million in Q4 2025.
• A 5-year average of $87.1 million and a median of $84.1 million in 2026 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average jumped 54.8% — and 2025, when it plunged 48.8%.
• Tracing FTH's Assets Average over 5 years: stood at $123.6 million in 2022, then tumbled by 36.87% to $78.0 million in 2023, then tumbled by 36.8% to $49.3 million in 2024, then tumbled by 48.8% to $25.2 million in 2025, then jumped by 233.3% to $84.1 million in 2026.
• The last three Assets Average figures came in at $84.1 million (Q1 2026), $25.2 million (Q4 2025), and $29.7 million (Q3 2025), per Business Quant data.